Ruina Bai

Xiyuan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Correction: A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol.

Correction: A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol.

Journal: Frontiers in cardiovascular medicine

Published: April 13, 2026

The Bidirectional Relationship Between Myocardial Infarction and Depression: Risk Factors, Mechanisms, and Interventions.

The Bidirectional Relationship Between Myocardial Infarction and Depression: Risk Factors, Mechanisms, and Interventions.

Journal: Biomedicines

Published: September 28, 2025

Efficacy and safety of Shugan Jieyu Capsule in the treatment of depressive state after acute coronary syndrome: study protocol for a multicenter randomized controlled trial.

Efficacy and safety of Shugan Jieyu Capsule in the treatment of depressive state after acute coronary syndrome: study protocol for a multicenter randomized controlled trial.

Journal: Frontiers in psychiatry

Published: August 12, 2025

Xinyue capsule treatment on long-term outcomes in patients with stable coronary artery disease after PCI: A 10-year observational follow-up.

Xinyue capsule treatment on long-term outcomes in patients with stable coronary artery disease after PCI: A 10-year observational follow-up.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 23, 2025

The effects of low-carbohydrate diet on glucose and lipid metabolism in overweight or obese patients with T2DM: a meta-analysis of randomized controlled trials.

The effects of low-carbohydrate diet on glucose and lipid metabolism in overweight or obese patients with T2DM: a meta-analysis of randomized controlled trials.

Journal: Frontiers in nutrition

Published: October 23, 2024

A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol.

A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol.

Journal: Frontiers in cardiovascular medicine

Published: October 20, 2024

Qingxin Jieyu Granule alleviates myocardial infarction through inhibiting neutrophil extracellular traps via activating ANXA1/FPR2 axis.

Qingxin Jieyu Granule alleviates myocardial infarction through inhibiting neutrophil extracellular traps via activating ANXA1/FPR2 axis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 23, 2024

Vascular smooth muscle cell phenotypic switching in atherosclerosis.

Vascular smooth muscle cell phenotypic switching in atherosclerosis.

Journal: Heliyon

Published: May 30, 2024

Efficacy of Danlou tablets in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multicenter prospective cohort study.

Efficacy of Danlou tablets in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multicenter prospective cohort study.

Journal: Frontiers in cardiovascular medicine

Published: April 19, 2024

Genetic analyses of the bidirectional associations between common mental disorders and asthma.

Genetic analyses of the bidirectional associations between common mental disorders and asthma.

Journal: Frontiers in psychiatry

Published: January 18, 2024

Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review.

Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review.

Journal: Frontiers in pharmacology

Published: August 27, 2023

P2y12 inhibitor monotherapy after 1-3 months dual antiplatelet therapy in patients with coronary artery disease and chronic kidney disease undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

P2y12 inhibitor monotherapy after 1-3 months dual antiplatelet therapy in patients with coronary artery disease and chronic kidney disease undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Journal: Frontiers in cardiovascular medicine

Published: March 30, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026